214 related articles for article (PubMed ID: 36409609)
1. Anti-HK antibody inhibits the plasma contact system by blocking prekallikrein and factor XI activation in vivo.
Chen ZL; Singh PK; Horn K; Calvano MR; Kaneki S; McCrae KR; Strickland S; Norris EH
Blood Adv; 2023 Apr; 7(7):1156-1167. PubMed ID: 36409609
[TBL] [Abstract][Full Text] [Related]
2. Anti-HK antibody reveals critical roles of a 20-residue HK region for Aβ-induced plasma contact system activation.
Chen ZL; Singh PK; Horn K; Strickland S; Norris EH
Blood Adv; 2022 May; 6(10):3090-3101. PubMed ID: 35147669
[TBL] [Abstract][Full Text] [Related]
3. High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation.
Mohammed BM; Sun MF; Cheng Q; Litvak M; McCrae KR; Emsley J; McCarty OJT; Gailani D
J Thromb Haemost; 2024 Jan; 22(1):225-237. PubMed ID: 37813198
[TBL] [Abstract][Full Text] [Related]
4. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
Joseph K; Tholanikunnel BG; Kaplan AP
J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.
Renné T; Gailani D; Meijers JC; Müller-Esterl W
J Biol Chem; 2002 Feb; 277(7):4892-9. PubMed ID: 11733491
[TBL] [Abstract][Full Text] [Related]
6. Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms.
Singh PK; Chen ZL; Horn K; Norris EH
Res Pract Thromb Haemost; 2022 Oct; 6(7):e12815. PubMed ID: 36254255
[TBL] [Abstract][Full Text] [Related]
7. Nucleic acids as cofactors for factor XI and prekallikrein activation: Different roles for high-molecular-weight kininogen.
Ivanov I; Shakhawat R; Sun MF; Dickeson SK; Puy C; McCarty OJ; Gruber A; Matafonov A; Gailani D
Thromb Haemost; 2017 Apr; 117(4):671-681. PubMed ID: 28124063
[TBL] [Abstract][Full Text] [Related]
8. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
[TBL] [Abstract][Full Text] [Related]
9. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
Steen Burrell KA; Layzer J; Sullenger BA
J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
[TBL] [Abstract][Full Text] [Related]
10. The bradykinin-forming cascade: a historical perspective.
Kaplan AP
Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
[TBL] [Abstract][Full Text] [Related]
11. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
Mitropoulos KA
Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
[TBL] [Abstract][Full Text] [Related]
12. The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells.
Mahdi F; Shariat-Madar Z; Schmaier AH
J Biol Chem; 2003 Nov; 278(45):43983-90. PubMed ID: 12944405
[TBL] [Abstract][Full Text] [Related]
13. Molecular modeling of the prekallikrein structure provides insights into high-molecular-weight kininogen binding and zymogen activation.
Hooley E; McEwan PA; Emsley J
J Thromb Haemost; 2007 Dec; 5(12):2461-6. PubMed ID: 17922805
[TBL] [Abstract][Full Text] [Related]
14. Titanium is a potent inducer of contact activation: implications for intravascular devices.
Litvak M; Shamanaev A; Zalawadiya S; Matafonov A; Kobrin A; Feener EP; Wallisch M; Tucker EI; McCarty OJT; Gailani D
J Thromb Haemost; 2023 May; 21(5):1200-1213. PubMed ID: 36696212
[TBL] [Abstract][Full Text] [Related]
15. Structures of factor XI and prekallikrein bound to domain 6 of high-molecular weight kininogen reveal alternate domain 6 conformations and exosites.
Li C; Barroeta AB; Wong SS; Kim HJ; Pathak M; Dreveny I; Meijers JCM; Emsley J
J Thromb Haemost; 2023 Sep; 21(9):2378-2389. PubMed ID: 37068593
[TBL] [Abstract][Full Text] [Related]
16. Protease activity in single-chain prekallikrein.
Ivanov I; Verhamme IM; Sun MF; Mohammed B; Cheng Q; Matafonov A; Dickeson SK; Joseph K; Kaplan AP; Gailani D
Blood; 2020 Feb; 135(8):558-567. PubMed ID: 31800958
[TBL] [Abstract][Full Text] [Related]
17. The Plasma Kallikrein-Kininogen Pathway Is Critical in the Pathogenesis of Colitis in Mice.
Wang B; Yang A; Zhao Z; He C; Liu Y; Colman RW; Dai J; Wu Y
Front Immunol; 2018; 9():21. PubMed ID: 29467753
[TBL] [Abstract][Full Text] [Related]
18. Plasma kallikrein structure reveals apple domain disc rotated conformation compared to factor XI.
Li C; Voos KM; Pathak M; Hall G; McCrae KR; Dreveny I; Li R; Emsley J
J Thromb Haemost; 2019 May; 17(5):759-770. PubMed ID: 30801944
[TBL] [Abstract][Full Text] [Related]
19. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens.
Sugi T; McIntyre JA
J Autoimmun; 2001 Nov; 17(3):207-14. PubMed ID: 11712858
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
